EDGAR Filing Documents for 0001193125-16-621892

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-16-621892

Filing Date

2016-06-15

Accepted

2016-06-15 07:50:07

Documents

Effectiveness Date

2016-06-15

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d176310d8k.htm	DEFA14A	32819
2	EX-2.1	d176310dex21.htm	EX-2.1	556723
3	EX-2.2	d176310dex22.htm	EX-2.2	60831
4	EX-2.3	d176310dex23.htm	EX-2.3	20391
5	EX-10.1	d176310dex101.htm	EX-10.1	80598
6	EX-10.2	d176310dex102.htm	EX-10.2	18486
7	EX-99.1	d176310dex991.htm	EX-99.1	16600
	Complete submission text file	0001193125-16-621892.txt		787592

Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304

Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777

Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36830 | Film No.: 161714388
SIC: 2834 Pharmaceutical Preparations